Glyoxalase 1 expression analysis by immunohistochemistry in breast cancer.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 25 08 2020
accepted: 09 10 2020
pubmed: 4 11 2020
medline: 29 9 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

Glyoxalase-1 (GLO-1) is the key enzyme in aldehyde defence in cancer cells. We here evaluated the prognostic impact and association with clinico-pathological parameters and relapse-free as well as overall survival in tumor samples from 187 breast cancer patients. The determined GLO1-immunoreactive score (GLO1-IRS) did not correlate with parameters such as grading, size, hormone receptors or ki67. However, an association of GLO1-IRS with the advanced glycation end product N

Identifiants

pubmed: 33142109
pii: S0344-0338(20)32112-9
doi: 10.1016/j.prp.2020.153257
pii:
doi:

Substances chimiques

AGER protein, human 0
Biomarkers, Tumor 0
NF-E2-Related Factor 2 0
NF-kappa B 0
NFE2L2 protein, human 0
Receptor for Advanced Glycation End Products 0
VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0
N(6)-carboxymethyllysine 70YDX3Z2O7
ERBB2 protein, human EC 2.7.10.1
Receptor, ErbB-2 EC 2.7.10.1
GLO1 protein, human EC 4.4.1.5
Lactoylglutathione Lyase EC 4.4.1.5
Lysine K3Z4F929H6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

153257

Informations de copyright

Copyright © 2020 Elsevier GmbH. All rights reserved.

Auteurs

Caroline Scheifele (C)

Department of Pathology, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Qi Zhu (Q)

Department of Pathology, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Atanas Ignatov (A)

Department of Obstetrics and Gynecology, Otto von Guericke University Magdeburg, Gerhart-Hauptmann Str. 35, Magdeburg, Germany.

Thomas Kalinski (T)

Department of Pathology, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Norbert Nass (N)

Department of Pathology, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. Electronic address: Norbert.nass@med.ovgu.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH